13.04.2021 16:36:08
NOVARTIS N (CHI-X)
80.02
CHF
-0.72
-0.89%
13.04.2021 16:20
 
Chart
Indexzugehörigkeit
Name
CBOE EUROPE 50 (EUR) (NET TOTAL RETURN)
CBOE EUROPE 50 (EUR) (PRICE RETURN)
CBOE EUROPE ALL COMPANIES (EUR) (NET TOTAL RETURN)
CBOE EUROPE ALL COMPANIES (EUR) (PRICE RETURN)
CBOE EUROPE ALL COMPANIES EX UK (EUR) (NET TOTAL RETURN)
CBOE EUROPE ALL COMPANIES EX UK (EUR) (PRICE RETURN)
CBOE EUROPE HEALTHCARE SECTOR (EUR) (NET TOTAL RETURN)
CBOE EUROPE HEALTHCARE SECTOR (EUR) (PRICE RETURN)
CBOE SWITZERLAND 20 (CHF) (NET TOTAL RETURN)
CBOE SWITZERLAND 20 (CHF) (PRICE RETURN)
DJ GLOBAL TITANS 50 INDEX (PRICE) (USD)
DJ HEALTH CARE TITANS 30 INDEX (PRICE) (EUR)
DJ HEALTH CARE TITANS 30 INDEX (PRICE) (USD)
DOW JONES SWITZERLAND INDEX (PRICE) (CHF)
DOW JONES SWITZERLAND INDEX (PRICE) (USD)
DOW JONES SWITZERLAND TIT. 30 INDEX (PRICE) (CHF)
DOW JONES SWITZERLAND TIT. 30 INDEX (PRICE) (USD)
S&P EUROPE 350
SMI EXPANDED INDEX
STOXX 50 INDEX
STOXX EUROPE 400 INDEX (PRICE) (EUR)
STOXX EUROPE 50 INDEX NR
STOXX EUROPE 600 INDEX
STOXX EUROPE 600 INDEX NR
Kursdaten
Kurs 80.02 Eröffnung 80.67
Diff. absolut -0.72 Tages-Hoch 80.69
Diff. % -0.89 % Tages-Tief 79.37
Geld 80.01 Vol. Geld 1
Brief 80.02 Vol. Brief 52
Volumen 270477 Umsatz 21578564.28
Schlusskurs vom 12.04.2021 80.74 Volatilität in % 19.49
Börse CHI-X Letzter Handel 13.04.2021 / 16:20
Währung CHF Aktualisierungsstand 13.04.2021 / 16:36
Kursentwicklung (berechnet mit Vortageskursen)
Zeitraum Perf. Hoch Tief
2021 0.00% 82.7 76.6
1 Woche -0.65% 81.6 80.0
1 Monat 3.62% 82.3 77.8
3 Monate 0.00% 82.7 76.6
6 Monate 0.00% 82.7 76.6
1 Jahr 0.00% 82.7 76.6
3 Jahre 0.00% 82.7 76.6
Benchmark:
4.46
26.51
1.13
SMI
SMI
SMI
2021
2019
2020
{"2021":{"performance":0,"chartHeight":8.8538614316935,"year":2021,"ID_NOTATION":"322628083"},"2019":{"ID_NOTATION":"322628083"},"2020":{"ID_NOTATION":"322628083"}}
{"2019":{"performance":26.51,"chartHeight":26.561584295081,"year":2019,"BENCHMARK_NAME":"SMI","ID_NOTATION":"1555183"},"2020":{"performance":1.13,"chartHeight":9.5262067121732,"year":2020,"BENCHMARK_NAME":"SMI","ID_NOTATION":"1555183"},"2021":{"performance":4.46,"chartHeight":17.07899387821,"year":2021,"ID_NOTATION":"1555183","BENCHMARK_NAME":"SMI"}}
{"2019":{"performance":25.56,"chartHeight":26.561584295081,"year":2019,"ID_NOTATION":"193736","BENCHMARK_NAME":"EStoxx50"},"2020":{"performance":-5.37,"chartHeight":18.100454467432,"year":2020,"ID_NOTATION":"193736","BENCHMARK_NAME":"EStoxx50"},"2021":{"performance":11.52,"chartHeight":22.299292720398,"year":2021,"ID_NOTATION":"193736","BENCHMARK_NAME":"EStoxx50"}}
{"2019":{"performance":23.76,"chartHeight":26.281724748865,"year":2019,"ID_NOTATION":"324977","BENCHMARK_NAME":"DJI"},"2020":{"performance":6.87,"chartHeight":19.455602462465,"year":2020,"ID_NOTATION":"324977","BENCHMARK_NAME":"DJI"},"2021":{"performance":10.26,"chartHeight":21.662077183149,"year":2021,"ID_NOTATION":"324977","BENCHMARK_NAME":"DJI"}}
{"2019":{"performance":22.39,"chartHeight":25.955012834026,"year":2019,"ID_NOTATION":"60972397","BENCHMARK_NAME":"Nikkei"},"2020":{"performance":18.06,"chartHeight":24.772720199038,"year":2020,"ID_NOTATION":"60972397","BENCHMARK_NAME":"Nikkei"},"2021":{"performance":8.41,"chartHeight":20.568263406865,"year":2021,"ID_NOTATION":"60972397","BENCHMARK_NAME":"Nikkei"}}
{"2019":{"performance":26.45,"chartHeight":26.561584295081,"year":2019,"ID_NOTATION":"20735","BENCHMARK_NAME":"DAX"},"2020":{"performance":3.67,"chartHeight":16.006493242864,"year":2020,"ID_NOTATION":"20735","BENCHMARK_NAME":"DAX"},"2021":{"performance":10.91,"chartHeight":22,"year":2021,"ID_NOTATION":"20735","BENCHMARK_NAME":"DAX"}}
Kennzahlen
Anzahl Mitarbeiter 105.794
Börsenwert 199.616 Mrd. CHF
mehr Kennzahlen
Stammdaten
NOVARTIS AG NAMENS-A..
ISIN CH0012005267
Valor 1200526
Symbol NOVN
Währung CHF
Branche Pharma
Sektor Chemie / Pharma / Ge..
Land Schweiz
Heimatbörse SWX
Nachrichten von AWP von NOVARTIS N
Datum Zeit Titel
30.03.2021 07:31 Novartis erhält EU-Zulassung für Kesimpta
29.03.2021 10:22 Novartis schliesst US-Standort für Gentherapie
23.03.2021 13:44 Novartis-MS-Mittel Kesimpta wird in Kanada zugelassen
22.03.2021 07:17 Novartis ernennt Karen Hale zur Chefjuristin
10.03.2021 18:49 Novartis-CEO: Spielen die Rolle, die wir aufgrund Fokussierung spielen können
Weitere AWP-Nachrichten
Weitere Börsenplätze
Name Währung Kurs +/- +/-% Volumen
SIX Swiss Exchange CHF 80.02 -0.66 -0.82 2943633
BATS Europe CHF 80.02 -0.73 -0.90 223786
CHI-X CHF 80.02 -0.72 -0.89 270477
Turquoise CHF 80.01 -0.67 -0.83 113467
Tradegate EUR 80.05 0.00 0.00 16350
Nasdaq other OTC USD 86.70 -0.82 -0.93 525
Frankfurt EUR 80.16 -0.22 -0.27 1589
München EUR 80.10 -0.14 -0.17 55
Hamburg EUR 80.19 -0.06 -0.07 1000
Düsseldorf EUR 80.18 -0.09 -0.11 4
Berlin EUR 80.40 0.23 0.29 40
Hannover EUR 80.10 -0.18 -0.22 -